Floriana Centritto

Retinoids and breast cancer: from basic studies to the clinic and back again.

S. Garattini, M. Fratelli, A. Zambelli, 2014, Cancer treatment reviews.

Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with coamplification of ERBB2 and RARA

P Ubezio, P. Ubezio, M. Fratelli, 2012, Oncogene.

Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro.

E. Sartori, E. Ratner, D. Silasi, 2017, Gynecologic oncology.

All-trans-retinoic Acid Modulates the Plasticity and Inhibits the Motility of Breast Cancer Cells

M. Fratelli, E. Garattini, M. Terao, 2015, The Journal of Biological Chemistry.

Cellular and molecular determinants of all-trans retinoic acid sensitivity in breast cancer: Luminal phenotype and RARα expression

S. Garattini, M. Lupi, P. Ubezio, 2015, EMBO molecular medicine.

T-DM1, a novel antibody-drug conjugate, is highly effective against uterine and ovarian carcinosarcomas overexpressing HER2

S. Canevari, P. Schwartz, T. Rutherford, 2014, Clinical & Experimental Metastasis.

Polymerase ε (POLE) ultra-mutated tumors induce robust tumor-specific CD4+ T cell responses in endometrial cancer patients.

E. Ratner, D. Silasi, P. Schwartz, 2015, Gynecologic oncology.

Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome

A. Tomassetti, S. Canevari, M. Sensi, 2015, Oncotarget.